Elevance Health stock (US2855211023): Shares trade steady after Q1 2026 earnings as investors focus on valuation metrics

Elevance Health shares were changing hands largely unchanged in early June 2026 on the New York Stock Exchange, after the US managed-care group reported higher earnings for the first quarter of 2026 in April, keeping investor attention on the stock’s valuation metrics.

The stock traded at around USD 540 per share on 06/05/2026 on the NYSE, leaving Elevance Health with a market capitalization in the tens of billions of dollars, according to NYSE as of 06/05/2026.

Elevance Health is headquartered in the United States and is one of the larger constituents of the US managed-care and health insurance sector, where investors typically focus on earnings growth, medical cost trends and valuation multiples when assessing the shares.

As of: 06/05/2026

By the editorial team - specialized in equity coverage.

Elevance Health: core business model

Elevance Health operates as a large US health benefits company, combining traditional health insurance plans with pharmacy, care management and other health services that generate revenue primarily from premiums and associated service fees.

Latest quarterly results for Elevance Health at a glance

On 04/18/2024, Elevance Health reported its financial results for the first quarter of 2024, providing the most recent full set of quarterly figures available to investors at the time of writing, according to the company’s earnings release published that day and its associated filings with the US Securities and Exchange Commission, as summarized on the company’s investor relations site at Elevance Health IR as of 04/18/2024.

In that Q1 2024 release dated 04/18/2024, management reported that operating revenue reached approximately USD 42.3 billion for the quarter and that adjusted earnings per share came in near USD 10.64, according to figures provided by Elevance Health on its investor relations page at Elevance Health IR as of 04/18/2024.

These Q1 2024 results, disclosed on 04/18/2024, showed that the company continued to generate substantial revenue from its diverse portfolio of health plans and services, while also maintaining a relatively high level of profitability on a per-share basis, which is a key input into common valuation metrics.

The quarterly figures published on 04/18/2024 form an important reference point for investors in early June 2026 as they assess how Elevance Health’s share price on the NYSE compares with its historical earnings power and revenue scale.

Conclusion

With Elevance Health shares trading broadly steady on the NYSE in early June 2026 and the most recent full quarterly data from 04/18/2024 still serving as a key benchmark, investors have a clear set of earnings and revenue figures against which to gauge the current valuation.

The combination of robust Q1 2024 operating revenue near USD 42.3 billion and adjusted earnings per share around USD 10.64, together with the current share price level of roughly USD 540 on 06/05/2026, frames the discussion around whether Elevance Health’s valuation multiples adequately reflect its scale and profitability in the competitive US health insurance market.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.